Pharmaceutical Manufacturing – Furosemide Tablets

This contract involves the manufacture and supply of Furosemide 20 mg tablets, packaged in 90-count bottles, under an FDA-approved ANDA or NDA. The manufacturing process must comply with current Good Manufacturing Practices (cGMP) to ensure high quality and safety standards. The contract emphasizes a commitment to an uninterrupted supply of the medication, highlighting the importance of reliability and consistency in delivery. The solicitation is issued by the Department of Defense's DLA Troop Support, targeting pharmaceutical manufacturing with a NAICS code of 325412. Although some specific details such as the place of performance and contact information are not provided, the contract has a clear timeline with responses due by May 21, 2026. This opportunity is structured as a subcontract and reflects the government's ongoing need for essential pharmaceutical products to support military and defense operations.